Gallahue Kieran

DirectorIntersect ENT, Inc. (XENT) · full profile →Form 4 · filed May 16, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
3 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2022Tender(U)3K$28.25$92K5K
May 13, 2022Tender(U)5K$28.25$142K0
May 13, 2022Tender(U)29K$28.25$827K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2022Tender(U)25K$28.25$706K0
May 13, 2022Tender(U)13K$28.25$374K0
May 13, 2022Tender(U)120K$28.25$3.4M0
May 13, 2022Tender(U)6K$28.25$170K0
May 13, 2022Tender(U)3K$28.25$98K0
May 13, 2022Tender(U)10K$28.25$273K0
May 13, 2022Tender(U)3K$28.25$96K0
May 13, 2022Tender(U)6K$28.25$162K0
May 13, 2022Tender(U)13K$28.25$353K0
May 13, 2022Tender(U)82K$28.25$2.3M0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-22-004073) within minutes of acceptance. Every field above traces to the original document. Verify it directly: